Latest Breaking News On - Insulin data expected mid january - Page 1 : comparemela.com

/PRNewswire/ Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of.

United statesSouth koreaNadav kidronZach herschfusOramed pharmaceuticals incCompany contactDrug administrationOramed pharmaceuticalsMedicox co ltdExchange commissionTopline pivotal phaseInsulin data expected mid januaryAchieved primaryDeal signedCommercialize oral insulinChief executive officer